Medi Analytika India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.92 Cr
as on 04-07-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 M
as on 04-07-2024
- Revenue -13.82%
(FY 2023)
- Profit -0.09%
(FY 2023)
- Ebitda 22.65%
(FY 2023)
- Net Worth 14.35%
(FY 2023)
- Total Assets 27.20%
(FY 2023)
About Medi Analytika India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.92 Cr.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aarya Ramesh, Adithya Ramesh, Buvaneswari Ramesh, and One other member serve as directors at the Company.
- CIN/LLPIN
U65991TN2000PTC044741
- Company No.
044741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai - 600 020., Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medi Analytika India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Ramasubramanian  | Managing Director | 17-Apr-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aarya Ramesh | Director | 08-Sep-2021 | Current |
| Adithya Ramesh | Director | 08-Sep-2021 | Current |
| Buvaneswari Ramesh | Director | 07-Nov-2011 | Current |
Financial Performance of Medi Analytika India.
Medi Analytika India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.82% decrease. The company also saw a slight decrease in profitability, with a 0.09% decrease in profit. The company's net worth Soared by an impressive increase of 14.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Analytika India?
In 2023, Medi Analytika India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 May 2004 | ₹1.50 M | Satisfied |
How Many Employees Work at Medi Analytika India?
Medi Analytika India has a workforce of 11 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Analytika India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Analytika India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
